REQUEST A DEMO
Total
USD $0.00
Search more companies

Benu Vaistine Lietuva, UAB (Lithuania)

Main Activities: Pharmacies and Drug Stores
Full name: Benu Vaistine Lietuva, UAB Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Benu Vaistine Lietuva, UAB is an enterprise based in Lithuania. Its main office is in Kaunas. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was established on March 18, 2002. 406 (2025) employees currently work for Benu Vaistine Lietuva, UAB. In its most recent financial highlights, the company reported a net sales revenue increase of 11.3% in 2025. In, 2025, the company’s net profit margin increased by 0.41%.

Headquarters
Karmelavos sen. Ramuciu k. Gamybos g. 4
Kaunas; Kaunas County; Postal Code: LT-54468

Contact Details: Purchase the Benu Vaistine Lietuva, UAB report to view the information.

Basic Information
Total Employees:
Purchase the Benu Vaistine Lietuva, UAB report to view the information.
Registered Capital:
Purchase the Benu Vaistine Lietuva, UAB report to view the information.
Financial Auditors:
Purchase the Benu Vaistine Lietuva, UAB report to view the information.
Incorporation Date:
March 18, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Benu Vaistine Lietuva, UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.3%
Total operating revenue
11.3%
Net Profit (Loss) for the Period
61.41%
Total equity
2.19%
Net Profit Margin
0.41%
Return on Equity (ROE)
2.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?